Litcius/Paper detail

Clonal Relatedness and Plasmid Profiling of Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing <i>Klebsiella Pneumoniae</i> Clinical Isolates

Muhammad Usman Qamar, Hasan Ejaz, Timothy R. Walsh, Asad Ali Shah, Dunia A. Al Farraj, Roua M. Alkufeidy, Noorah A. Alkubaisi, Sidrah Saleem, Shah Jahan

2021Future Microbiology26 citationsDOI

Abstract

Aim: Carbapenem-resistant Klebsiella pneumoniae (CR-KP) particularly New Delhi metallo-β-lactamase (NDM) is a serious public health concern globally. The aim of the study to determine the molecular epidemiology of blaNDM-producing clinically isolated K. pneumoniae. Methods: Carbapenem-resistant K. pneumoniae isolates (n = 100) were collected from tertiary care hospital Lahore. Isolates were confirmed by VITEK® 2 system and MALDI-TOF. Minimum inhibitory concentration was performed by VITEK 2 and molecular characterization was done by PCR, PFGE, DNA hybridization and replicon typing. Results: Of 90 MBL-producing K. pneumoniae, 75 were NDM producers; 60 were NDM-1 and 11 NDM-5. A total of 27 K. pneumoniae belonged to ST11 and 14 to ST147. NDM-positive isolates were 100% resistant to β-lactam antibiotics except for colistin. 13.3% isolates carried blaNDM on ∼140 kb plasmids. A total of 32 (52.4%) isolates were positive for IncA/C and 18 (29.5%) IncF/II. Conclusion: The extensively resistant lineage of NDM-producing K. pneumoniae is prevalent in the clinical setting.

Topics & Concepts

Klebsiella pneumoniaeMicrobiologyColistinBiologyMolecular epidemiologyCarbapenemPlasmidDrug resistanceAntibioticsTigecyclinePulsed-field gel electrophoresisGenotypeGeneGeneticsEscherichia coliAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyPharmaceutical and Antibiotic Environmental Impacts